Sorafenib Tablet, Film Coated
Product Images NDC 51990-201

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sorafenib (NDC 51990-201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Yabao Pharmaceutical Co., Ltd. Beijing, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig1.jpg (Fig1)

FDA Label Image

Fig3.jpg (Fig3)

Fig3.jpg (Fig3)
This appears to be a table showing the results of a clinical trial comparing the effectiveness of Sorafenib to Placebo in treating some medical condition with a significant difference in median survival time between the two groups. Not enough context is provided to determine the specifics and purpose of the study.*
FDA Label Image

200 mg Label (Label 120s)

200 mg Label (Label 120s)
This is a description of a medication labeled as NDC 51990-201-12. Each film-coated tablet contains Sorafenib 200 mg sorafenib equivalent to Tablets, USP 274 mg sorafenib tosylate. It is recommended to follow the accompanying information for dosage purposes. The medication should be stored in a dry place within the temperature range of 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. It is advised to keep these medications out of the reach of children.*
FDA Label Image

200 mg Label (Label 60s)

200 mg Label (Label 60s)
This is a description of a medication called Sorafenib. It comes in 200mg tablets and is coated with a film. Each tablet contains 200mg of Sorafenib equivalent to 207mg Sorafenib tosylate. Specific storage instructions are provided, including a recommended temperature range and storage in a dry place. Additionally, it is stated to keep the medication out of reach of children. For further information on the use of this medication, the accompanying prescribing information should be consulted.*
FDA Label Image
FDA Label Image

Structural Formula (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.